M Du1, M Wu, D Fu, S Yang, J Chen, K Wilson, T J Lyons. 1. Harold Hamm Diabetes Center and Section of Endocrinology and Diabetes, University of Oklahoma Health Sciences Center, HHDC Suite 2900, Oklahoma City, OK 73104, USA.
Abstract
AIMS/HYPOTHESIS: Blood-retina barrier leakage in diabetes results in extravasation of plasma lipoproteins. Intra-retinal modified LDLs have been implicated in diabetic retinopathy (DR), but their effects on retinal pigment epithelial (RPE) cells and the added effects of extravasated modified HDLs are unknown. METHODS: In human retinas from individuals with and without diabetes and DR, immunohistochemistry was used to detect ApoB, ApoA1 and endoplasmic reticulum (ER) stress markers. In cell culture, human RPE cells were treated with native LDL (N-LDL) or heavily-oxidised glycated LDL (HOG-LDL) with or without pretreatment with native HDL (N-HDL) or heavily-oxidised glycated HDL (HOG-HDL). Cell viability, oxidative stress, ER stress, apoptosis and autophagy were assessed by Cell Counting Kit-8 assay, dichlorofluorescein assay, western blotting, immunofluorescence and TUNEL assay. In separate experiments, RPE cells were treated with lipid oxidation products, 7-ketocholesterol (7-KC, 5-40 μmol/l) or 4-hydroxynonenal (4-HNE, 5-80 μmol/l), with or without pretreatment with N-HDL or HOG-HDL. RESULTS: ApoB, ApoA1 staining and RPE ER stress were increased in the presence of DR. HOG-LDL but not N-LDL significantly decreased RPE cell viability and increased reactive oxygen species generation, ER stress, apoptosis and autophagy. Similarly, 4-HNE and 7-KC decreased viability and induced ER stress. Pretreatment with N-HDL mitigated these effects, whereas HOG-HDL was less effective by most, but not all, measures. CONCLUSIONS/ INTERPRETATION: In DR, extravascular modified LDL may promote RPE injury through oxidative stress, ER stress, autophagy and apoptosis. N-HDL has protective effects, but HOG-HDL is less effective. Extravasation and modification of HDL may modulate the injurious effects of extravasated modified LDL on the retinal pigment epithelium.
AIMS/HYPOTHESIS: Blood-retina barrier leakage in diabetes results in extravasation of plasma lipoproteins. Intra-retinal modified LDLs have been implicated in diabetic retinopathy (DR), but their effects on retinal pigment epithelial (RPE) cells and the added effects of extravasated modified HDLs are unknown. METHODS: In human retinas from individuals with and without diabetes and DR, immunohistochemistry was used to detect ApoB, ApoA1 and endoplasmic reticulum (ER) stress markers. In cell culture, humanRPE cells were treated with native LDL (N-LDL) or heavily-oxidised glycated LDL (HOG-LDL) with or without pretreatment with native HDL (N-HDL) or heavily-oxidised glycated HDL (HOG-HDL). Cell viability, oxidative stress, ER stress, apoptosis and autophagy were assessed by Cell Counting Kit-8 assay, dichlorofluorescein assay, western blotting, immunofluorescence and TUNEL assay. In separate experiments, RPE cells were treated with lipid oxidation products, 7-ketocholesterol (7-KC, 5-40 μmol/l) or 4-hydroxynonenal (4-HNE, 5-80 μmol/l), with or without pretreatment with N-HDL or HOG-HDL. RESULTS:ApoB, ApoA1 staining and RPE ER stress were increased in the presence of DR. HOG-LDL but not N-LDL significantly decreased RPE cell viability and increased reactive oxygen species generation, ER stress, apoptosis and autophagy. Similarly, 4-HNE and 7-KC decreased viability and induced ER stress. Pretreatment with N-HDL mitigated these effects, whereas HOG-HDL was less effective by most, but not all, measures. CONCLUSIONS/ INTERPRETATION: In DR, extravascular modified LDL may promote RPE injury through oxidative stress, ER stress, autophagy and apoptosis. N-HDL has protective effects, but HOG-HDL is less effective. Extravasation and modification of HDL may modulate the injurious effects of extravasated modified LDL on the retinal pigment epithelium.
Authors: E Nobecourt; M J Davies; B E Brown; L K Curtiss; D J Bonnet; F Charlton; A S Januszewski; A J Jenkins; P J Barter; K-A Rye Journal: Diabetologia Date: 2007-01-10 Impact factor: 10.122
Authors: Ronald Klein; A Richey Sharrett; Barbara E K Klein; Scot E Moss; Aaron R Folsom; Tien Y Wong; Frederick L Brancati; Larry D Hubbard; David Couper Journal: Ophthalmology Date: 2002-07 Impact factor: 12.079
Authors: Mingyuan Wu; Ying Chen; Kenneth Wilson; Alin Chirindel; Michael A Ihnat; Yongxin Yu; Michael E Boulton; Luke I Szweda; Jian-Xing Ma; Timothy J Lyons Journal: Invest Ophthalmol Vis Sci Date: 2008-03-24 Impact factor: 4.799
Authors: Dongxu Fu; Jeremy Y Yu; Mingyuan Wu; Mei Du; Ying Chen; Souzan A Abdelsamie; Yanchun Li; Junping Chen; Michael E Boulton; Jian-Xing Ma; Maria F Lopes-Virella; Gabriel Virella; Timothy J Lyons Journal: J Lipid Res Date: 2014-03-10 Impact factor: 5.922
Authors: Sarah X Zhang; Jacey H Ma; Maulasri Bhatta; Steven J Fliesler; Joshua J Wang Journal: Prog Retin Eye Res Date: 2014-12-18 Impact factor: 21.198
Authors: Bruce A Pfeffer; Libin Xu; Ned A Porter; Sriganesh Ramachandra Rao; Steven J Fliesler Journal: Exp Eye Res Date: 2016-02-13 Impact factor: 3.467
Authors: Mei Du; Laura Otalora; Ashley A Martin; Gennadiy Moiseyev; Phillip Vanlandingham; Qilong Wang; Rafal Farjo; Alexander Yeganeh; Alexander Quiambao; Krysten M Farjo Journal: Mol Cell Biol Date: 2015-06-08 Impact factor: 4.272